Your symptoms describe pleural effusion (PE).
PE is the top side effect of dasatinib.
https://www.ncbi.nlm.nih.gov/pubmed/28082112
https://www.sciencedirect.com/science/article/pii/S2152265016305687
https://www.webmd.com/lung/pleural-effusion-symptoms-causes-treatments#1
See your doctor to verify you have P.E. developing. Treatment usually consists of stopping dasatinib until the PE clears. Once PE is corrected, you would re-start dasatinib on a reduced dose (20 mg in your case). If PE re-occurs, you may have to change drugs.
However - there is emerging data that CML patients who do experience pleural effusions due to dasatinib also show a dramatic response to the drug treating their CML. If you can stay on dasatinib, you are likely to have a very good CML response especially on the lower dose.
http://www.bloodjournal.org/content/124/21/3142?sso-checked=true
From the paper linked above:
"Conclusion: The incidence of PE on dasatinib treatment is associated with advanced patient age, lymphocyte value at 1 month (especially in the CD56-positive fraction), and achievement of an early molecular response."
So - maybe having PE develop is a good thing ???
The key is PE is manageable and should be watched closely. Don't dismiss your symptoms - see your doctor. An x-ray will confirm. If you can stay on dasatinib - stay on dasatinib, but don't let your doctor keep the same dose you are on now. Insist on a lower dose and see if you continue to respond. You can always change drugs if you don't. I have a suspicion your CML is getting destroyed.